The viral vector and plasmid DNA manufacturing market offers growth opportunities in gene therapies, contract manufacturing, and emerging markets like Asia-Pacific. Key trends include rising demand ...
Hopewell-based team delivers on ProBio's promise of speed, quality, and reliability—offering a transparent, fixed-cost model and ≥85% supercoiled plasmid DNA in record time for clinical programs. The ...
Success in gene and cell therapy is driving demand for plasmid DNA which is a key reagent to produce viral vectors, both for commercial products as well as the breadth of different vectors for the ...
The use of in vivo electroporation (EP) as a therapeutic gene delivery approach has been successfully used in a variety of applications including cancer therapy and the regulation of protein levels to ...
As cell and gene therapies, mRNA vaccines and other cutting-edge meds come into their own, developers have put a strain on the industry's supply chain. That’s where biopharma building block outfits ...
In the development of DNA vaccines and cell and gene therapies, manufacturing plasmid DNA creates a crucial bottleneck. Such a slowdown could intensify with the market for manufacturing DNA plasmids ...
Hosted on MSN
Plasmid perfection starts with smart design
From gene therapy to vaccine development, plasmids are vital tools — but only if they’re designed, optimized, and verified with precision. Advances in codon optimization, long-read sequencing, and ...
Plasmid DNA isolation is an important technique in molecular biology, however, achieving effective high-throughput automation of this method has proven to be challenging. Analytik Jena and SynbiCITE ...
Scientists have reported large DNA structures in some archaea that defy easy categorization. When the microbiologist Jillian Banfield and her colleagues started combing through samples of mud from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results